Valneva Aktie
2,78
EUR
-0,05
EUR
-1,63
%
3,32
EUR
+1,16
EUR
+53,75
%
Es gab keine Analysen zu dieser Aktie in den letzten sechs Monaten.
Werbung
Kursziele im Branchenvergleich
Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
---|---|---|---|---|---|
Amgen Inc. | 0 | 0 | 0 | - | - |
AstraZeneca PLC | 6 | 3 | 0 | 136,60 GBP | - |
BB Biotech AG | 0 | 0 | 0 | - | - |
BioNTech (ADRs) | 4 | 2 | 0 | 131,67 USD | +37,43% |
CanSino Biologics Inc. Registered Shs -A- | 0 | 0 | 0 | - | - |
CureVac | 0 | 1 | 0 | - | - |
EVOTEC SE | 2 | 3 | 0 | 9,96 EUR | +42,86% |
Johnson & Johnson | 0 | 0 | 0 | - | - |
Moderna Inc | 0 | 2 | 1 | 67,33 USD | +153,50% |
MorphoSys | 0 | 0 | 0 | - | - |
Novavax Inc. | 0 | 0 | 0 | - | - |
QIAGEN N.V. | 5 | 1 | 0 | 48,00 EUR | +20,53% |
Sanofi S.A. | 6 | 3 | 0 | 115,12 EUR | +31,85% |
Shanghai Fosun Pharmaceutical (Group) Co Ltd (A) | 0 | 0 | 0 | - | - |
Sinopharm Group Co Ltd (H) | 0 | 0 | 0 | - | - |
Sinovac Biotech LtdShs | 0 | 0 | 0 | - | - |
Valneva | 0 | 0 | 0 | - | - |